BioNexus Gene Lab Corp Quarterly Return On Assets in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
BioNexus Gene Lab Corp quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q2 2024.
  • BioNexus Gene Lab Corp Return On Assets for the quarter ending June 30, 2024 was -19.5 %, a 183% decline year-over-year.
  • BioNexus Gene Lab Corp annual Return On Assets for 2023 was -27 %, a 546% decline from 2022.
  • BioNexus Gene Lab Corp annual Return On Assets for 2022 was -4.18 %, a 154% decline from 2021.
  • BioNexus Gene Lab Corp annual Return On Assets for 2021 was 7.77 %, a 76.4% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -19.5 -12.6 -183% Apr 1, 2024 Jun 30, 2024
Q1 2024 -25.4 -20.1 -376% Jan 1, 2024 Mar 31, 2024
Q4 2023 -27 -22.8 -546% Oct 1, 2023 Dec 31, 2023
Q3 2023 -34.1 -32.9 -2613% Jul 1, 2023 Sep 30, 2023
Q2 2023 -6.9 -9.75 -342% Apr 1, 2023 Jun 30, 2023
Q1 2023 -5.34 -9.87 -218% Jan 1, 2023 Mar 31, 2023
Q4 2022 -4.18 -12 -154% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.26 -6.24 -125% Jul 1, 2022 Sep 30, 2022
Q2 2022 2.85 -2.76 -49.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 4.53 -2.05 -31.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 7.77 -25.1 -76.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 4.98 -101 -95.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 5.61 -71.6 -92.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 6.58 -61.3 -90.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 32.9 +50.2 Oct 1, 2020 Dec 31, 2020
Q3 2020 106 +124 Jul 1, 2020 Sep 30, 2020
Q2 2020 77.2 Apr 1, 2020 Jun 30, 2020
Q1 2020 67.9 Jan 1, 2020 Mar 31, 2020
Q4 2019 -17.3 Oct 1, 2019 Dec 31, 2019
Q3 2019 -17.7 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.